Solvent Composition Effects on the Structural Properties of the Aβ42 Monomer from the 3D-RISM-KH Molecular Theory of Solvation

The Journal of Physical Chemistry. B
Nikolay BlinovAndriy Kovalenko

Abstract

Structural characterization of amyloid (A)β peptides implicated in Alzheimer's disease is a challenging problem due to their intrinsically disordered nature and their high propensity for aggregation. Only limited information is currently available from experiments on conformational properties and aggregation pathways of the peptides in cellular environments. In silico modeling complements experimental information, providing atomistic insight into structure and dynamics of different Aβ species. All-atom explicit solvent molecular dynamics (MD) simulations with a properly selected force field can deliver reliable structural and dynamic information. In the case of intrinsically disordered Aβ peptides, enhanced sampling simulations beyond the nanosecond time scale are required to obtain statistically meaningful results even for simple solvent conditions. To overcome the challenges of conformational sampling in crowded cellular environments, alternative approaches have to be used, including postprocessing of MD data. In this study, we employ the statistical-mechanical, three-dimensional reference interaction site model with the Kovalenko-Hirata closure integral equation molecular theory of solvation to describe solvent composition e...Continue Reading

References

Mar 20, 1991·Journal of Molecular Biology·Y Goto, S Aimoto
Mar 8, 1984·The New England Journal of Medicine·S B Prusiner
Jun 28, 1994·Biochemistry·J TalafousM G Zagorski
Jan 1, 1993·Annual Review of Biophysics and Biomolecular Structure·S B Zimmerman, A P Minton
Feb 1, 1996·Journal of Molecular Graphics·W HumphreyK Schulten
Aug 28, 1999·The Journal of Biological Chemistry·D M WalshD B Teplow
Aug 15, 2000·Journal of Structural Biology·S ZhangJ P Lee
Feb 28, 2002·The Journal of Biological Chemistry·Pascal Kienlen-CampardJean-Noël Octave
Aug 1, 2002·The Journal of Biological Chemistry·Youcef Fezoui, David B Teplow
Oct 24, 2002·Journal of Computational Chemistry·Araz JakalianChristopher I Bayly
Jan 4, 2003·Nature Reviews. Neuroscience·Claudio Soto
Jul 25, 2003·Biochimica Et Biophysica Acta·Damien Hall, Allen P Minton
Apr 30, 2004·Journal of Computational Chemistry·Junmei WangDavid A Case
Dec 14, 2004·The Journal of Biological Chemistry·Fusheng YangGregory M Cole
Mar 11, 2005·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Dominic M WalshDennis J Selkoe
Nov 3, 2005·Journal of the American Chemical Society·Takashi ImaiFumio Hirata
Feb 14, 2006·Trends in Biochemical Sciences·Claudio SotoJoaquín Castilla
Jul 20, 2006·The Journal of Chemical Physics·Takashi ImaiFumio Hirata
Oct 24, 2006·Biophysical Journal·Piotr DrabikAndriy Kovalenko
Jan 25, 2007·Nature Reviews. Molecular Cell Biology·Christian Haass, Dennis J Selkoe
Feb 9, 2007·Journal of Neurochemistry·Dominic M Walsh, Dennis J Selkoe
Apr 3, 2007·Journal of Molecular Biology·Nikolaos G SgourakisAngel E Garcia
Jun 7, 2007·Nature Reviews. Neuroscience·Frank M LaFerlaSalvatore Oddo
Jul 31, 2007·Protein Science : a Publication of the Protein Society·Takashi ImaiFumio Hirata
Aug 28, 2007·Archives of Biochemistry and Biophysics·Huan-Xiang Zhou
Oct 2, 2007·Biophysical Journal·Seiichiro TanizakiMichael Feig
Oct 4, 2007·The Journal of Biological Chemistry·Lucila SaavedraElena Posse de Chaves
Nov 21, 2007·Proceedings of the National Academy of Sciences of the United States of America·Loren StaggPernilla Wittung-Stafshede
Jan 29, 2008·Nature Chemical Biology·Brian Y FengBrian K Shoichet

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.